Oncodna
OncoDNA is a company specialized in precision medicine for the treatment of cancer.
Oncodna has raised €19M across 1 funding round from 2 investors, most recently a Series B round in Feb 2020. Based in Gosselies, Belgium; founded 2012; active in Healthtech. Data as of 28 Oct 2026.
Total raised
€19M
€19,000,000
Funding rounds
1
Investors
2
distinct backers
Active since
2020-02
latest 2020-02
Funding by year
EUR raised per yearOncodna — funding by year — interactive chart.
Data table
| Oncodna — funding by year | |
|---|---|
| 2020 | €19M |
Signals
High confidenceRaise-next likelihood9
base rate 48% for Series B
- ▼ Dormant (no round in 3+ cohort gaps)
- ▼ Low backer re-investment
Timing: dormant vs cohort gap · momentum unknown. Funding-only estimates, not predictions and not investment advice — see signals.
Funding rounds
1 round| Date | Stage | Amount | Investors | |
|---|---|---|---|---|
| 2020-02-14 | Series B | €19M | Swisscanto Private Equity,Vesalius Biocapital Partners | View deal → |
Related news
Similar companies
same sector or country- Philips€2.6BNetherlands · Healthtech
- Imec€2.5BBelgium · Deeptech
- Isomorphic Labs€2.3BUK · Healthtech
- CMR Surgical€1.5BUK · Healthtech
- Roivant Sciences€1.1BSwitzerland · Healthtech
- Kpler€1.0BBelgium · Software
Global coverage: FundingData